Foundation Medicine disclosed after the close of the market on Tuesday that it has filed a request with the US Securities and Exchange Commission to withdraw a proposed public offering of up to $150 million of its common stock. The Cambridge, Mass.-based cancer genetics diagnostics company said it wants to withdraw its planned public offering "due to market conditions." Since Foundation Medicine filed its Form S-1 for the public offering with the SEC on March 20, its share price has slid 35 percent.
Help employers find you! Check out all the jobs and post your resume.
